Skip to main content

Peer Review reports

From: Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents

Original Submission
4 Jun 2018 Submitted Original manuscript
28 Jun 2018 Author responded Author comments - Hari Krishna Ananthula
Resubmission - Version 2
28 Jun 2018 Submitted Manuscript version 2
21 Jul 2018 Reviewed Reviewer Report - Josef Yayan
27 Jul 2018 Reviewed Reviewer Report - Peter Penson
3 Aug 2018 Reviewed Reviewer Report - Frantisek Trejtnar
3 Sep 2018 Author responded Author comments - Hari Krishna Ananthula
Resubmission - Version 3
3 Sep 2018 Submitted Manuscript version 3
21 Sep 2018 Reviewed Reviewer Report - Peter Penson
29 Sep 2018 Reviewed Reviewer Report - Frantisek Trejtnar
11 Nov 2018 Author responded Author comments - Hari Krishna Ananthula
Resubmission - Version 4
11 Nov 2018 Submitted Manuscript version 4
Publishing
13 Nov 2018 Editorially accepted
4 Dec 2018 Article published 10.1186/s40360-018-0270-x

You can find further information about peer review here.

Back to article page